Introduction {#S1}
============

Aging is considered as one of the largest risk factors for both diseases and mortality ([@B9]). Age-related diseases include sensory changes (e.g., hearing loss), systemic (e.g., high blood pressure) and neurodegenerative disorders (e.g., Alzheimer's disease) among others ([@B18]). Furthermore, both the number and proportion of elderly people are expected to increase at an accelerating rate in the future (the United Nations estimated a 230% increase -- from 901 million to 2.092 billion -- in the population of people of 60 years or above from 2015 to 2050; [@B42]). Both longevity and healthspan (defined as the "period of time during which humans and non-human animals are generally healthy and free from serious or chronic illness"; quote from [@B44]) are direct consequences of (a healthy) aging and are equally important from both social and economic points of view.

The genetics of aging and longevity has been studied in multiple species, including *C. elegans* (e.g., [@B10]), fruit fly (e.g., [@B22]), mice (e.g., [@B34]), dogs (see [@B14] for a summary), and humans (e.g., [@B13]). Based on these studies, longevity is known to be influenced by both genetic and environmental factors ([@B29]), with an estimated heritability of 15--30% in humans (e.g., [@B13]); in a comparative study, [@B46] synthesized the results currently available on longevity-associated genes (LAGs) from yeast, *C. elegans*, fruit fly and mouse and studied their orthologs in more than 200 species. More recently, a study showed that heritability of lifespan might have been overestimated in the past and an upper limit estimate of ∼7% was proposed ([@B36]). However, extreme longevity (i.e., longevity of centenarians) was reported to have a higher heritability than longevity itself ([@B39]). Several mechanisms of aging are either directly (genomic instability, telomere attrition, and epigenetic alterations) or indirectly related to genetics \[cell senescence ([@B47]), loss of proteostasis and stem cell exhaustion ([@B29])\]. Furthermore, multiple genetic pathways have already been identified to be linked to longevity, such as the insulin/insulin-like growth factor signaling pathway, the telomere maintenance pathway or the DNA damage response and repair machinery ([@B8]; [@B31]; [@B6]). All of these pathways are crucial to sustain normal cell functions and are related to the previously mentioned genetic hallmarks.

For many reasons, the companion dog is an especially promising model organism for translational approaches in aging research ([@B11]; [@B21]; [@B38]). Firstly, dogs have a much shorter life expectancy than humans -- 10--13 years on average in dogs ([@B1]; [@B23]; [@B17]) vs. 72 years in humans (2016 estimation; [@B45]) -- making aging-related longitudinal studies much shorter in time. Secondly, dog breeds show a huge phenotypic and genetic variability ([@B24]; [@B32]), which can also be observed in longevity (e.g., [@B19]; [@B17]). Dogs also have more shared haplotype sequences with humans than rodents do ([@B28]). Furthermore, they also experience the rich and variable environment and lifestyles their human owners live in (unlike laboratory animals, which are kept in a highly controlled environment) and therefore similar environmental factors influence their everyday life, aging and life expectancy ([@B14]) -- albeit, at least two major exogenous factors affecting longevity (namely, diet and physical activity) may be considerably different between the two species.

Finally, dogs are prone to multiple, spontaneously developing age-related diseases late in their lives that can be considered as analogs of multiple human diseases (e.g., the canine cognitive dysfunction, which is similar to Alzheimer's disease; see [@B5] for more details). The undeniable relevance of this final point and the previously mentioned other advantages of the companion dog make this species one of the best model animals to study aging. In addition, it is also expected that the obtained results will be more applicable to humans than those conducted on canonical laboratory animals. In a review article, [@B38] summarized our state of the art knowledge about the genetic pathways involved in aging in dogs.

The study of aging and longevity is of great importance. It enables us to better understand the process of aging itself, which in turn could lead to the promotion of a healthy lifestyle among the general population and help mankind to successfully cope with the long-term socio-economical consequences of an aging population. In addition, a deeper understanding of extreme longevity and its background is fundamental for biomedical research to develop efficient medicine against age-related diseases (both for treatment and prevention). Furthermore, it was highlighted before in humans, that the prevalence of multiple age-related diseases was lower among the offspring of centenarians and that longevity-related genes provide a certain level of 'protection' against cognitive decline and neurodegeneration (e.g., [@B37] after [@B12]). However, at this point it is worth mentioning that genomes of centenarians also contain buffered deleterious alleles (e.g., [@B15]). Moreover, in dogs, the identification of genes and other genetic loci linked to longevity would enable breeders to select more efficiently for longevity within the breeds. As a result of selection on such genetic loci in dogs, the proportion of the beneficial alleles could be increased within the breed under selection, increasing the average life expectancy of the given breed and simultaneously improving the quality of life of the companion pets and their owners alike.

[@B12] studied six centenarians (105--109 years old) to investigate the genetic background of extreme longevity in humans. These centenarians lived ∼50% longer compared to the average human lifespan (72 years, [@B45]). Given this definition of extreme longevity and the average lifespan of companion dogs (10--13 years; [@B1]; [@B23]; [@B17]), dogs older than ∼17 years can be considered as dogs of extreme age. Mixed-breed dogs are known to live longer: [@B17] studied the lifespan of more than 12,000 dogs and found the average length of lifespan of mixed-breed individuals to be 15 years. Therefore, extreme longevity in their case corresponds to ∼22.5 years of age. In the data published by Inoue et al., 13 dogs lived 22--25 years (no dogs above the age of 25 were recorded in their study), corresponding to 0.1% of the studied population, or 1.16% of the mixed-breed individuals, assuming that all individuals of age 22--25 were mixed-breed. These numbers suggest that there is a sufficiently large population of dogs with an extreme longevity to be included in age-related studies in the future.

In this preliminary study we analyzed the whole genome sequence of two extremely old dogs, who lived 22 and 27 years -- or approximately 50--80% longer, than the average lifespan of a mixed-breed dog (alternatively, 90--135% longer, than the average canine lifespan). Our primary aim was to investigate the genetic background of longevity and identify mutations at coding regions that could have contributed to their long lifespan. Our secondary aims were to compare the obtained results to the results of [@B12], to extend our understanding of extreme longevity and to promote the companion dog to be used in age-related research. Indeed, this is the first such study in canines, although based on the results of [@B17], Methuselah dogs are available for the study of aging and longevity.

Materials and Methods {#S2}
=====================

The canine reference genome (*CanFam 3.1* version), as well as all relevant information related to it (e.g., gene annotations) were downloaded from Ensembl (version 94, released in October, 2018; [@B16]). Since the canine reference genome excludes the Y-chromosome, this chromosome was not included in the analysis.

The Dogs Under Analysis {#S2.SS1}
-----------------------

Two dogs of extreme age (i.e., Methuselah dogs) were examined in this study: a 27 years old mixed-breed intact male (Buksi, lived in Sárrétudvari, Hungary; ID: old_rep1; buccal swab sample collected at the age of 26) and a 22 years old mixed-breed neutered female dog (Kedves, lived in Ócsa, Hungary; ID: old_rep2; blood sample collected at the age of 22, [Figure 1](#F1){ref-type="fig"}). The distance between the living areas of the dogs was approximately 180 km. Both dogs lived in a rural environment in Hungary where they were allowed to roam around freely. Therefore, both of them could feed on wild prey animals (e.g., mice) beyond their daily meals. The male dog had a diet of raw chicken and table scraps and had been fed this way through his whole life, according to the owners. He lived in a horse riding center and had contact with friendly people (both unfamiliar and familiar) who went for horse riding on a daily basis, as well as with other dogs at the farm and in the village. The female dog was fed with commercial dog food *ad libitum*. She was a pet dog of a dog shelter manager, and also had plenty of contacts with people visiting the shelter, the management staff and other dogs. Both animals were in good physical condition at the time of sampling. The male dog weighted around 13--14 kg, while the female dog weighted around 16--18 kg. Both of them were regularly vaccinated against rabies.

![The two Methuselah dogs participating in this study: Buksi **(left)** (photo taken by Attila Dávid Molnár) and Kedves **(right)** (photo taken by Linda Gerencsér). The images are published with the written consent of owners and all identifiable person(s).](fgene-11-00315-g001){#F1}

Both dogs spent their entire life with their owners and their family, thus at least five adult persons -- including the dogs' veterinarians -- who had no conflict of interest, confirmed the age of each dog.

Whole-Genome Sequence Data {#S2.SS2}
--------------------------

DNA samples were isolated and sequenced by Omega Biosciences (Norcross, GA, United States). Sequencing was performed on an Illumina HiSeq X Ten instrument, producing 150 basepairs long paired-end reads. A total of ∼2 × 481 and ∼2 × 473 million reads were sequenced for the two samples.

On-Line Databases {#S2.SS3}
-----------------

Our working hypothesis was that common variants (i.e., variants segregating in dogs with an average lifespan) were less likely to positively affect longevity than variants uniquely present in individuals with extreme longevity. Therefore, our primary focus was on the short genetic variations that are uniquely present in the Methuselah dogs sequenced within the framework of this study and are absent in dogs with an average lifespan. In order to exclude the most common variants, all SNPs and indels previously identified and published in at least one of three on-line databases were excluded. These databases included: (1) the Dog Genome SNP Database (DoGSD), which is "a data container for the variation information of dog/wolf genomes" (quote from the DoGSD website accessed on 25/06/2019^[1](#footnote1){ref-type="fn"}^) and contained SNP data from 127 individual samples, including purebred and mixed-breed individuals alike; (2) the database created by the \[American\] National Human Genome Research Institute (NHGRI) based on the whole-genome sequence of 722 dogs; (3) the Broad Institute's dog SNP database, which was created as part of the Canine Genome Sequencing Project. The last database was created for the *CanFam 2.0* genome version and therefore positions were lifted over to the current genome version (*CanFam 3.1*), which was used in this study; 16,388 SNPs (15,951 of which were on autosomes) were removed in the process, out of the 2,544,508 from the original study ([Table 1](#T1){ref-type="table"}).

###### 

Number of SNPs in three, previously published databases.

  Database                               38 autosomes + X chromosome^1^   38 autosomes
  -------------------------------------- -------------------------------- --------------
  DoGSD database ([@B3])                 54644335                         52318004
  Broad Institute database ([@B27])^2^   2528120                          2466855
  NHGRI database ([@B35])                20269614                         19693593
  Total number of non-redundant SNPs     61180804                         58623548

1

+MT in case of the DoGSD database.

2

After lift-over from CanFam v2.0 to v3.1.

All animals in these databases were considered to be of average age. Although, the exact age of death of these individuals is unknown and therefore there might be some misclassification of these individuals. However, [@B17] studied the cemetery data of more than 12000 dogs and found that only 0,1% of them (*n* = 13) lived 22--25 years of age and none lived for 25 + years. Therefore, the probability of misclassification of the ∼800 dogs in the database is negligible.

The NHGRI's database included indel mutations as well (*n* = 12,300,815), which were used to remove the common indels. It is important to note that since indels were not included in two of the databases, the common indel variants were detected in a smaller pool of individuals and therefore indels that are otherwise common among dogs with an average lifespan might have remained in the dataset.

Candidate Gene Set {#S2.SS4}
------------------

In a previous study, [@B12] discovered 89 novel non-synonymous SNPs via exome sequencing in six centenarians by targeting a predefined set of 988 genes. These genes were selected from previous publications and were from pathways that are known to be involved in either aging or longevity. In this study we included an additional 157 genes that were related to autophagy and other pathways, which also may affect aging (adding up to 1,145 genes in total) and identified their canine homologs (in total, 1,062 homologs were found). Although the related genetic pathways were already associated with aging, only limited information is currently available regarding the contribution of individual genes to aging either in humans or in dogs ([@B38]).

WGS-Data Processing {#S2.SS5}
-------------------

The general outline of the analysis is shown on [Figure 2](#F2){ref-type="fig"}. Following sequencing, a quality control step of the raw reads using the FastQC program ([@B2]; [RRID:SCR_014583](https://scicrunch.org/resolver/RRID:SCR_014583)) was implemented. Alignment was performed with the *mem* command of the BWA aligner software ([@B26]; BWA, [RRID:SCR_010910](https://scicrunch.org/resolver/RRID:SCR_010910)), using the standard parameter settings except for the "-M" option, which was used to make the output files compatible with the Picard software toolkit ([@B4]; Picard, [RRID:SCR_006525](https://scicrunch.org/resolver/RRID:SCR_006525)). Alignment quality control was assessed by calculating alignment statistics with Samtools ([@B25]; SAMTOOLS, [RRID:SCR_002105](https://scicrunch.org/resolver/RRID:SCR_002105)) and Picard.

![Outline of the performed study.](fgene-11-00315-g002){#F2}

Short variants (SNPs and short insertions-deletions) were then identified with the GATK software ([@B43]; GATK, [RRID:SCR_001876](https://scicrunch.org/resolver/RRID:SCR_001876)). Short variants were called using the *HaplotypeCaller* command of GATK and separately for each chromosome to accelerate the variant calling step. The standard parameter values were used during variant calling as well, except for the number of allowed processors, which was increased from 1 to 8. Files containing the variants from different chromosomes were then merged with the *MergeVCFs* command (Picard) and the different types of variants (SNPs and indels) were separated with the *SelectVariants* command of GATK. This latter step was necessary, because different filtering options were applied for the different types of mutations.

Variants were filtered based on quality scores using the *VariantFiltration* tool (GATK). In case of both SNPs and indels, the recommended hard-filtering options were used. For SNPs, the applied filtering options were: QD \< 2.0; FS \> 60.0; MQ \< 40.0; MQRankSum \< 12.5; ReadPosRankSum \< −8.0; SOR \> 3.0. For indels, the recommended filtering options were used, except for the inbreeding coefficient, which parameter was excluded, as this option requires 10 or more individuals in the analysis (the applied filtering options in case of indels are: QD \< 2.0; FS \> 200.0; ReadPosRankSum \< −20-0; SOR \> 10.0). After quality-based variant filtration, the SNP and indel variants that were identified in both individuals were determined, as these variants are of greatest interest. The overlap category in the tables hereinafter will refer to this set of SNPs and indels.

Downstream Analysis {#S2.SS6}
-------------------

All SNP and indel mutations published in at least one of the three canine databases were excluded from the analysis. Ensembl's *Variant Effect Predictor* software ([@B30]; Variant Effect Predictor, [RRID:SCR_007931](https://scicrunch.org/resolver/RRID:SCR_007931)) was used to identify mutations with a potentially high impact on the phenotype and the genes incorporating one or more such mutations were identified. These genes were then compared with the age-related gene set defined above. In parallel, protein domain information was downloaded for all protein-coding genes from Ensembl for the *CanFam 3.1* genome version and non-synonymous SNP mutations located at these genomic regions were identified. The distribution of these SNPs as well as the function of the affected genes was investigated.

Results {#S3}
=======

In spite of the similar sequencing depth between the two individuals, depth of coverage differed significantly between them after alignment to the reference genome. The average depth of coverage across the whole genome was 46.1 and 60.1 for old_rep1 and old_rep2, respectively.

[Table 2](#T2){ref-type="table"} shows the number of SNPs and indels identified in this study before and after filtering out the previously published mutations (*n* = 61,180,804; see [Table 1](#T1){ref-type="table"}). The two Methuselah dogs were very similar in these numbers and a large proportion of both SNPs (64%) and indels (52%) overlapped between them. The number of unpublished SNPs was also similar between the two individuals (1.4% of all detected SNP), but only ∼17% of those SNPs were shared between them ([Table 2](#T2){ref-type="table"}). Indels showed a similar picture as SNPs, except for the unpublished indels (on average 17% of the indels were novel) and their overlap between the two individuals (62%), which were considerably higher.

###### 

Number of variants discovered in the two individuals with extreme longevity as well as the number of overlapping mutations.

                                 old_rep1   old_rep2   Overlap
  ------------------------------ ---------- ---------- ---------
  Number of SNP                  4754086    4817227    3038929
  Number of SNP (autosomes)      4648426    4688907    2973573
  Number of unpublished SNP      41099      46375      7505
  Number of indels               552996     578712     295412
  Number of indels (autosomes)   521840     556968     280773
  Number of unpublished indels   97826      99698      62288

Most of the SNPs located in genes were found in introns (92%), while only a small proportion of them were located in exons (∼4.6%), out of which ∼2.4% were missense variants ([Table 3](#T3){ref-type="table"}; for a complete list of all categories, see [Supplementary Table S1](#DS1){ref-type="supplementary-material"}). The remaining SNPs were located in the 3′ and 5′ UTR regions (1,3 and 2%, respectively), and a small number of loss-of-function mutations (start codon lost, stop codon gained/lost mutations; ∼0.045% of the SNPs) were detected as well. Loss-of-function mutations were detected in 12 known genes, none of which overlapped between the two individuals:

###### 

Number of SNPs for different annotation categories.

  Annotation category     old_rep1   old_rep2   Overlap
  ----------------------- ---------- ---------- ---------
  5′ UTR variant          323        379        121
  Start lost              1          4          0
  Intron variant          15507      17277      2798
  Missense variant        422        411        76
  Synonymous variant      387        394        86
  Stop gained             5          5          0
  Stop lost               1          0          0
  Stop retained variant   199        248        30
  3′ UTR variant          323        379        121

The table also includes the unknown genes.

1.  Three genes had a start codon lost mutation: ENSCAFG00000007858, ENSCAFG00000011630, and ENSCAFG00000030632.

2.  Nine genes had a stop codon gain mutation in the gene body: ENSCAFG00000000433, ENSCAFG00000008061, ENSCAFG00000010498, ENSCAFG00000017946, ENSC AFG00000024414, ENSCAFG00000002007, ENSCAFG 00000004279, ENSCAFG00000029250, and ENSCAFG 00000032497.

Although intron variants usually do not affect protein expression levels directly, they might still influence gene expression by, e.g., modifying transcription factor binding sites. However, since no information was available about the location of transcription factor binding motifs on the canine genome, this could not be assessed in this study.

[Table 4](#T4){ref-type="table"} shows the number of genes that include SNP variants in either exons or regulatory regions (defined as 5 kb upstream and downstream of every protein coding gene) for the two animals and the shared set of SNPs between the two dogs (the number of SNPs is also shown). 327 novel exonic SNPs were detected in both dogs, while an additional 2505 exonic SNPs were identified in either one of them. Among the 327 shared SNPs, there were 67 missense mutations falling in 37 genes. In total, 13,334 SNPs were identified in regulatory regions, 1861 of which were shared between the two individuals, failing in 887 protein-coding genes. 31 of these genes were included in the age-related gene set as well. However, the investigation of the potential effect of these SNPs is not feasible from WGS-data only.

###### 

Number of SNPs located within known age-related genes and in their promoter regions.

                                                                        old_rep1      old_rep2      Overlap
  --------------------------------------------------------------------- ------------- ------------- ------------
  Number of longevity-related genes in dogs^1^                                        1062          
                                                                                                    
  Number of exonic SNP                                                  86621         86521         55159
  Number of novel exonic SNP                                            1371          1461          327
  Number of novel, missense SNP mutations                               376 (257)     361 (261)     67 (37)
  Number of age-related genes with missense mutation(s)                 9 (8)         16 (12)       1 (1)
                                                                                                    
  Number of genes with novel SNP in regulatory regions^2^               7014 (4370)   8181 (5005)   1861 (887)
  Number of age-related genes with mutations in regulatory regions^2^   411 (159)     464 (168)     200 (31)

Number of affected genes are shown in parenthesis.

1

The definition of longevity-related genes is provided in the materials and methods section;

2

defined as 5 kb upstream and downstream of gene body.

We previously identified from the literature a set of 1,062 genes that could possibly be related to aging and longevity. Out of these, 19 had novel missense mutations in the studied dogs, one of which (ENSCAFG00000014403) was found in both individuals. Based on its gene ontology (biological process category, inferred from electronic annotation by Ensembl), it is related to intracellular protein transport and long-term synaptic depression. A complete list of these 19 genes and their associated gene ontology IDs can be found in [Supplementary Table S2](#DS1){ref-type="supplementary-material"}. Three examples with associated gene ontologies are presented below:

1.  ENSCAFG00000024527: ion transport, chemical synaptic transmission,

2.  ENSCAFG00000001710: nervous system development, synaptic transmission -- cholinergic, excitatory postsynaptic potential,

3.  ENSCAFG00000018622: positive regulation of protein phosphorylation, leading edge cell differentiation, negative regulation of apoptotic process.

We also examined the possible effects of missense SNPs on the protein level. The missense SNPs located in protein domains were identified and evaluated across all protein-coding genes (see [Supplementary Table S3](#DS1){ref-type="supplementary-material"} for a complete list of these genes and their human homologs). In total, 180 genes hosting 248 missense mutations were identified, out of which 19 SNPs at nine genes were shared between the two individuals. Interestingly, in the case of the four genes (ENSCAFG00000002184, ENSCAFG00000002366, ENSCAFG00000009496, ENSCAFG00000018626) that included multiple shared SNPs between the two Methuselah dogs, the missense SNPs were close to each other (within 3--60 bp). These SNPs and the functions of the affected genes are discussed in detail in the Discussion section. Three example genes with missense mutations in protein domains as well as with some of the related GO terms are listed below:

1.  ENSCAFG00000003004: negative regulation of cell growth, negative regulation of apoptotic process;

2.  ENSCAFG00000004892: regulation of apoptotic process, positive regulation of extrinsic apoptotic signaling pathway;

3.  ENSCAFG00000019380: calcium ion transport, regulation of heart contraction, regulation of blood pressure, modulation of chemical synaptic transmission.

Analysis of Short Insertions and Deletions {#S3.SS1}
------------------------------------------

In the case of both individuals, 75% of the indels were 5 bp or shorter and 86% were shorter than 10 bp. Indels longer than 100 bp were extremely rare (∼0.36%). [Table 5](#T5){ref-type="table"} shows the number of protein coding genes with indels, grouped by impact category. Surprisingly, 524 genes hosted at least 1 short insertion/deletion of a measurable effect, according to Ensembl's *Variant Effect Predictor*. High impact categories in [Table 5](#T5){ref-type="table"} included mutations such as stop codon lost mutations (leading to elongated transcripts), indels resulting in frameshift mutations or insertions/deletions affecting coding regions. This group was the most numerous from the three impact categories.

###### 

Number of genes including at least 1 indel per impact category.

             Impact category^1^   Protein-coding genes   Protein-coding genes (excl. protein families)
  ---------- -------------------- ---------------------- -----------------------------------------------
  old_rep1   High                 367                    56
             Moderate             85                     27
             Low                  1                      0
                                                         
  old_rep2   High                 397                    60
             Moderate             95                     27
             Low                  0                      0

1

Impact category groups were defined by Ensembl as follows: HIGH -- The variant is assumed to have high (disruptive) impact in the protein, probably causing protein truncation, loss of function or triggering nonsense mediated decay; MODERATE -- A non-disruptive variant that might change protein effectiveness; LOW -- Assumed to be mostly harmless or unlikely to change protein behavior (

https://m.ensembl.org/info/genome/variation/prediction/predicted_data.html

).

Discussion {#S4}
==========

The study of aging and longevity holds the promise to increase human average longevity and healthspan. As it was pointed out earlier by multiple research groups (e.g., by [@B11] in their article entitled "Why is the dog an ideal model for aging research?"), the companion dog has the potential to overcome some of the limits of laboratory animals in aging and longevity studies and lead to results that are more applicable to humans. Here, we present the first, preliminary study on extreme longevity in companion dogs and also pointing at genes that could have played a role in their extreme longevity and thus can be candidates for verification studies conducted on larger cohorts.

We observed approximately 4.8 million SNPs and 550 1000 indels in the two test subjects. A large part of these short genetic variants overlapped between the two samples. This can be explained by the origin of the reference genome: the dog reference genome is originated from a female boxer and therefore it is not surprising that the mixed-breed individuals analyzed in this study carried different alleles at many loci. Therefore, the majority of the SNP and indel variants (and most likely other types of genetic variants as well) were shared between our two old subjects. The difference in the depth of coverage between the individuals did not influence the variant calling, suggesting that even the lower coverage (46x) was sufficient to detect SNP and indel variants. This is in accordance with the literature, where ∼30x coverage was proposed to be sufficient for SNP and indel calling ([@B40]).

Compared to SNP mutations, both the total number of previously unpublished indels and their overlap between the two individuals were considerably higher. This is because more novel indels were detected (∼17% of all indels) than novel SNPs. This might be for several reasons: first, only one of the three databases used to filter out known indels included short insertions/deletions and consequently many, otherwise common indels in the dog species might have remained in the dataset after filtering. Furthermore, the number of previously published indels was also ∼40% less numerous than the number of SNPs published in the same study and ∼80% less than the number of SNP in the combined SNP databases. Misalignment of reads, e.g., from different copy-number variant regions (including genes of the same gene family) might also have contributed to the higher number of shared indels. Such errors could have also occurred in the reference sequence, resulting in the detection of false positive indels. Finally, false positive indels could be also technical artifacts from the sequencing. As a result of these possible explanations, biologically relevant indels cannot be distinguished from false positives and further studies will be required for proper interpretation of these findings.

We examined the 12 genes with START and STOP codon mutations in more detail. First of all, all of the *loss of function* SNP mutations were in a heterozygous form, i.e., both of the individuals carried at least 1 complete copy of the affected 12 genes. In the case of the ENSCAFG00000008061 gene, the average depth of coverage at the SNP position was significantly lower (by ∼70%) when compared to the average depth of coverage of the whole genome of the same individual. The depth of coverage was especially low for a ∼440 bp long segment surrounding the mutation, with a short segment completely missing. This is probably because this particular region contains repetitive sequences with a high GC content (77% on average). This segment also partially overlaps with the first exon of the gene. In addition, the sequence coverage pattern of this particular region was very similar in the old_rep2 individual as well, in which the mutation was not detected. Therefore, this particular SNP is most likely a false positive, probably due to an incorrectly annotated gene on the reference genome. Out of the remaining 11 genes, 2 genes were without a human homolog and both of them were categorized as novel genes in Ensembl (i.e., only protein and cDNA sequence alignment support is available for the gene; these genes are: ENSCAFG00000017946 and ENSCAFG00000030632); currently no information is available on their functions that could link them to longevity and/or aging. The remaining nine genes had homologs in humans. In three of these genes (ENSCAFG00000011630, ENSCAFG00000007858 and the already mentioned ENSCAFG00000008061), the close proximity (50--500 bp regions) of the disruptive mutations was not conserved between dogs and humans based on the reference genome sequences. Furthermore, two genes with a human homolog (the previously mentioned ENSCAFG00000011630 and the ENSCAFG00000032497 gene) had a relatively low cDNA sequence similarity between the reference genomes of the two species (40--60% as compared to 80--97% in case of the remaining seven genes). The remaining seven genes included six known (ENSCAFG00000000433, ENSCAFG00000002007, ENSCAFG00000004279, ENSCAFG00000007858, ENSCAFG00 000010498, ENSCAFG00000029250) and one novel (ENSC AFG00000024414) gene and are likely to be true positive hits. Some of the stop codon gain mutations were located at the beginning of the genes (the ENSCAFG00000029250, ENSCAFG00000024414 genes, where the 28^*th*^ and 390^*th*^ nucleotide positions were affected, out of 3390 and 1755 nucleotides, respectively) having most likely a major, inactivating effect, while in the ENSCAFG00000010498 gene the mutation was located near the 3′ end of the gene (at the 3116^*th*^ nucleotide out of 3261) and might not be influential regarding protein functionality. Finally, it is worth mentioning that the potential loss-of-function effect of these mutations might be alleviated, if the genes are present in multiple copies in the canine genome, although this is unlikely in case of the genes with missing segments. In case of multicopy-genes, 1 (or more) copy of the gene could be a pseudogene, although currently none of these genes are marked as a pseudogene in Ensembl.

In our dataset, only a small proportion of the exonic mutations located in the pre-defined set of age-related genes were missense ([Table 4](#T4){ref-type="table"}). In comparison, [@B12] found 710 non-synonymous mutations (previously known and novel SNPs combined) at the 988 investigated genes when studying six human centenarians, out of which 89 SNPs were novel. We identified 670 novel missense mutations in genes in total, 24 of which were located in the pre-defined age-related genes. The increased number of novel SNPs identified in this study is partly because our data was not limited to a pre-defined set of genes and partly because less data was available in the canine SNP databases as compared to the human databases used by [@B12] and therefore it is likely that fewer common SNPs were filtered out. On the other hand, the smaller number of novel SNPs identified at the pre-defined age-related gene set is probably due to the smaller sample size in our study. Although the genetic pathways linked to these genes were already associated with aging and longevity, only one of them, the cholinergic receptor nicotinic alpha 3 subunit (canine ID: ENSCAFG00000001710; human ID: ENSG00000080644) was recently associated with longevity in three studies ([@B20]; [@B33]; [@B41], after [@B7]). Therefore, the remaining genes could be candidates for longevity in dogs and their association with longevity should be further investigated once more Methuselah dog samples become available.

Most of the genes with human homologs presumably linked to longevity did not include novel SNPs in the studied dogs. One of the most likely reasons to this observation is that aging and longevity are both extremely complex phenotypes, influenced by many genetic (e.g., additive genetic effects, dominance, epistasis, etc.) and environmental factors. This makes it difficult to identify single causative genetic factors behind extreme longevity, as the phenotype may result from entirely different settings of additive pro-longevity factors in each individual, especially in an inter-species comparison. Also, the current study lacks statistical power to identify significant associations between genetic and phenotypic variables. Finally, a third possible explanation could also be that mutations located in other genes may indirectly affect the function of longevity related genes by altering regulatory mechanisms. We identified several missense mutations in genes that had a function in translational processes (e.g., ENSCAFG00000005572 or ENSCAFG00000000104) and thus may affect the synthesis of proteins in general, including possible aging-related regulatory factors.

Based on the whole genome sequence data of 722 dogs (the NHGRI database; [@B35]), we could conclude that the missense SNP mutations at protein domains were mainly located in SNP-poor regions. The 722 dogs had on average 2.5 SNPs within a window of ∼290 bp around the missense mutations (only those at protein domains were considered). In contrast, the 2 Methuselah dogs had an average of 13.6 SNPs within the same windows, 10.7 of which were categorized as novel. This claim is further supported by the complete database we created by merging three publicly available SNP databases (a total of 61,180,804 SNPs were included): within a 200 bp symmetric window around these missense SNPs located at protein domains, ∼71% of the windows contained 5 SNPs or less in the database and 87% of them had 10 SNPs or less within the same window. Therefore, it is likely that the SNPs we identified in the Methuselah dogs are mostly functional. These closely located SNPs also influenced the same protein domains. Two of these genes (ENSCAFG00000002366 and ENSCAFG00000009496) and two others with 1 single SNP at protein domains (ENSCAFG00000023076 and ENSCAFG00000003564) are directly related to (the regulation of) gene transcription or translation, based on which we can formulate a hypothesis that there is a link between gene regulation and longevity. This is in accordance with the literature, where a recent study investigated 1805 LAGs across 205 species and found that "LAGs that have orthologs across a high number of phyla were enriched in translational processes" (quote from [@B46]). The remaining gene with more than 1 SNP mutation at a protein domain is related to immune response (ENSCAFG00000018626). Genes including more than 1 missense SNP mutation in either one of the two individuals revealed mostly the same pattern in SNP distribution with only a few exceptions.

472 genes included a total of 670 missense variants in either one or in both of the analyzed samples. Seven of these genes were part of the "Wnt signaling pathway," while 6 genes from each of the following pathways were also among the 472: inflammation mediated by chemokine and cytokine signaling pathway, the nicotinic acetylcholine receptor signaling pathway and the cadherin signaling pathway. Five genes were from the Alzheimer disease-presenilin pathway. These pathways define an interesting direction for future longevity research in dogs and model animals alike. In addition to the named genetic pathways, the genes themselves (as well as their homologs in other species) are principal candidates for association studies aiming to identify linkage between genes and long life expectancy.

Main Limitation of the Study {#S4.SS1}
----------------------------

The primary limitation of this study is the small sample size: for this study, two dogs of extreme age were sequenced, analyzed and compared to a set of 850 dogs of a presumably averagely long lifespan.

Aging is a complex trait with many genes, regulatory regions, environmental factors, etc. involved. Consequently, it is possible that dogs with an averagely long life also carry mutations that have a positive impact on the length of their lifespan and it is the combined effect of all loci and environmental factors that results in an overall shorter lifespan. Therefore, when we removed the previously published SNPs from the data, we might also have removed relevant mutations and focused only on the most promising targets. This was done because with samples from only two extremely old dogs, we did not have the statistical power to find all genomic loci influencing longevity. However, in the future, when more data become available, the mutations with smaller effects can also be investigated.

Consequently, this study is preliminary regarding the aim to detect mutations, which could be actually relevant in the context of lifespan determination in dogs. However, the findings of such studies can open up new ideas and directions for future investigations with higher statistical power.

Conclusion {#S5}
==========

Here we presented a preliminary study aiming to investigate the genetic background of longevity and aging in dogs. By analyzing all canine genes, we detected rare variants that might be linked to canine longevity and identified genes as potential LAGs. Based on their gene ontologies, these genes were related -- among others -- to gene transcription/translation and its regulation, to immune response and to the nervous system in general. Based on these preliminary results, we hypothesize a possible link between extreme longevity and the regulation of gene transcription/translation. In a recently published study, [@B46] independently came to the same conclusion. This hypothesis (namely: a crucial genetic requirement of extreme longevity lies within the *fine-tuning* (i.e., the superior calibration) of RNA (and thereof protein) production of an organism) is an interesting direction for future research aiming to better understand longevity.

We also identified several disrupted genes, albeit in heterozygous forms and therefore both examined individuals carried at least 1 intact copy of the affected 12 genes. The two Methuselah dogs sequenced for this study were unrelated mixed-breed individuals, suggesting that the mutations detected in both of them are relevant. Therefore, the shared SNPs we found in the two individuals (and the related genes) could be targets in future age-related research. This is further supported by the fact that none of these mutations were found in databases containing information from a total of 850 dogs with an average lifespan, representing a wide range of breeds as well as mixed-breed individuals from multiple countries.

Finally, it is worth mentioning that the younger dog analyzed in this study (aged 22) could be considered on the human scale as centenarian, while the older one (aged 27) would be a supercentenarian. A comparison of these two groups was infeasible in the current study due to the lack of statistical power, which would have led to unreliable results. However, once more DNA samples from dogs of extreme age become available, such a comparison would become possible and would aid us understanding the genetics of exceptionally extreme longevity.
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